Syverson Strege & Co’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-3
Closed -$13 664
2023
Q1
$13 Hold
3
﹤0.01% 666
2022
Q4
$18 Hold
3
﹤0.01% 319
2022
Q3
$0 Hold
3
﹤0.01% 348
2022
Q2
$0 Hold
3
﹤0.01% 359
2022
Q1
$0 Hold
3
﹤0.01% 342
2021
Q4
$0 Hold
3
﹤0.01% 504
2021
Q3
$0 Hold
3
﹤0.01% 483
2021
Q2
$0 Hold
3
﹤0.01% 304
2021
Q1
$0 Hold
3
﹤0.01% 293
2020
Q4
$0 Buy
+3
New ﹤0.01% 261